A Survey of American Psychiatrists' Attitudes Toward Classic Hallucinogens
Authors:
- Brian S. BarnettBBBrian S. Barnett
- Willie O. SiuWSWillie O. Siu
- Harrison G. Jr PopeHPHarrison G. Jr Pope
- 1 June 2018
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Nervous & Mental Disease
- Vol. 206 (6) , 476-480
Abstract
Recent years have seen renewed interest and research about the use of hallucinogens as possible agents in the treatment of psychiatric disorders. However, we are unaware of studies assessing the current attitudes of American psychiatrists regarding hallucinogens. Therefore, we e-mailed surveys to 1000 members of the American Psychiatric Association—250 resident-fellows and 750 attending psychiatrists. The response rate was 32.4%. Respondents tended to perceive hallucinogens as potentially hazardous and appropriately illegal for recreational purposes. However, a large minority expressed optimism about the potential use of hallucinogens for psychiatric treatment. Male and trainee respondents, as compared with female and attending respondents, reported less concern about the risks of hallucinogens and greater optimism about their therapeutic potential. Younger psychiatrists also seemed more optimistic. Optimism among trainees and younger psychiatrists may possibly reflect greater exposure to recent positive publications about hallucinogens and less awareness of more negative past reports.Keywords
This publication has 25 references indexed in Scilit:
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trialJournal of Psychopharmacology, 2016
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility studyThe Lancet Psychiatry, 2016
- Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept studyJournal of Psychopharmacology, 2015
- LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effectsJournal of Psychopharmacology, 2014
- Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening DiseasesJournal of Nervous & Mental Disease, 2014
- Self-inflicted Testicular Amputation in First Lysergic Acid Diethylamide UseJournal of Addiction Medicine, 2013
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage CancerArchives of General Psychiatry, 2011
- Do multiple outcome measures require p-value adjustment?BMC Medical Research Methodology, 2002
- A wilcoxon‐type test for trendStatistics in Medicine, 1985
- LYSERGIC ACID DIETHYLAMIDEJournal of Nervous & Mental Disease, 1960